Reed Elsevier PLC
8 August 2003
To: RNS
ISSUED ON BEHALF OF REED ELSEVIER PLC AND REED ELSEVIER NV
We have today received notification that on 8 August 2003, Mr A Prozes, a
director of Reed Elsevier PLC and Reed Elsevier NV, exercised a nil cost option
over 20,170 ordinary shares in Reed Elsevier PLC and 14,040 ordinary shares in
Reed Elsevier NV. The option was satisfied by the transfer of shares from the
Reed Elsevier Employee Benefit Trust ('the Trust'). Mr Prozes retained all of
the shares and, as a consequence, he now holds an interest in 96,525 Reed
Elsevier PLC ordinary shares and 67,774 Reed Elsevier NV ordinary shares.
Following the above transactions, the Trust now holds an interest in 6,460,289
Reed Elsevier PLC ordinary shares and 1,327,777 Reed Elsevier NV ordinary
shares.
The Trust is a discretionary employee benefit trust which is operated in
conjunction with Reed Elsevier's share option schemes, and which provides for
the transfer of shares to employees on the exercise of options granted under the
said schemes. Executive directors of Reed Elsevier PLC and Reed Elsevier NV are,
for technical disclosure purposes, deemed to be interested in the shares held by
the Trust, by virtue of being potential beneficiaries under the Trust.
From: REED ELSEVIER PLC
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.